🕵️ OSR Health, Inc. ($OSRH)
SEC insider & ownership activity, last 12 months · CIK 1840425 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Aug 19, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Bellevue Capital Management LLC | 87.7% | 13G | Feb 11, 2025 | filing ↗ | |
| Kuk Hyoun Hwang | 87.7% | 13G | Feb 11, 2025 | filing ↗ | |
| Bellevue Global Life Science Investors, LLC | 58.4% | 13G | Feb 11, 2025 | filing ↗ | |
| Bcm Europe Ag | 29.3% | 13G | Feb 11, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Aug 27, 2026 | filing ↗ |
| Other events (8.01) | Aug 25, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 19, 2026 | filing ↗ |
| Shareholder vote (5.07) | Aug 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Other events (8.01) | Jun 5, 2026 | filing ↗ |
| Material agreement (1.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 16, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 7, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 7, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 13, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jan 26, 2026 | filing ↗ |